Search research articles
Contact Us
Filters
Showing results (371-380 of 463) with videos related to
Page
of 47
Sort By:
Cancer Research
|
August 21, 2020
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer
Joseph D Schonhoft, Jimmy L Zhao, Adam Jendrisak, et al.
Annals of Surgical Oncology
|
October 5, 2024
Computed Tomography-Based Radiomics with Machine Learning Outperforms Radiologist Assessment in Estimating Colorectal Liver Metastases Pathologic Response After Chemotherapy
Georgios Karagkounis, Natally Horvat, Sofia Danilova, et al.
Clinical Colorectal Cancer
|
August 17, 2015
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes
Constantinos T Sofocleous, Elena G Violari, Vlasios S Sotirchos, et al.
Journal of the American College of Surgeons
|
April 27, 2016
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation
Julie N Leal, Alexsander K Bressan, Neeta Vachharajani, et al.
Nature Communications
|
October 10, 2018
Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer
Feng Chen, Kai Ma, Brian Madajewski, et al.
The American Surgeon
|
February 1, 2021
Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma
James S Strong, Elvira L Vos, Caitlin A Mcintyre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors
Archie N Tse, David S Klimstra, Mithat Gonen, et al.
Annals of Surgical Oncology
|
September 21, 2020
Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer
John M Creasy, Kristen M Cunanan, Jayasree Chakraborty, et al.
Abdominal Radiology (New York)
|
May 23, 2018
Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017
Marc J Gollub, Supreeta Arya, Regina Gh Beets-Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes
Owen A O'Connor, Carol Portlock, Craig Moskowitz, et al.
Page
of 47
Search research articles
Search
Showing results (371-380 of 463) with videos related to
Sort By:
Page
of 47
Cancer Research
|
August 21, 2020
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer
Joseph D Schonhoft, Jimmy L Zhao, Adam Jendrisak, et al.
Annals of Surgical Oncology
|
October 5, 2024
Computed Tomography-Based Radiomics with Machine Learning Outperforms Radiologist Assessment in Estimating Colorectal Liver Metastases Pathologic Response After Chemotherapy
Georgios Karagkounis, Natally Horvat, Sofia Danilova, et al.
Clinical Colorectal Cancer
|
August 17, 2015
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes
Constantinos T Sofocleous, Elena G Violari, Vlasios S Sotirchos, et al.
Journal of the American College of Surgeons
|
April 27, 2016
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation
Julie N Leal, Alexsander K Bressan, Neeta Vachharajani, et al.
Nature Communications
|
October 10, 2018
Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer
Feng Chen, Kai Ma, Brian Madajewski, et al.
The American Surgeon
|
February 1, 2021
Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma
James S Strong, Elvira L Vos, Caitlin A Mcintyre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors
Archie N Tse, David S Klimstra, Mithat Gonen, et al.
Annals of Surgical Oncology
|
September 21, 2020
Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer
John M Creasy, Kristen M Cunanan, Jayasree Chakraborty, et al.
Abdominal Radiology (New York)
|
May 23, 2018
Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017
Marc J Gollub, Supreeta Arya, Regina Gh Beets-Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes
Owen A O'Connor, Carol Portlock, Craig Moskowitz, et al.
Page
of 47